• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Preventice

Hillrom execs change their minds on BardyDx acquisition

March 3, 2021 By Chris Newmarker

Hillrom (NYSE:HRC) says closing conditions have not been met when it comes to the company’s previously planned $375 million acquisition of Bardy Diagnostics and its Carnation Ambulatory Monitor, or CAM patch. In response, BardyDx has sued Hillrom in the Delaware Court of Chancery, asking the court to order the merger to proceed because Hillrom’s argument […]

Filed Under: Business/Financial News, Cardiovascular, Diagnostics, Digital Health, Featured, Mergers & Acquisitions Tagged With: Bardy Diagnostics, Boston Scientific, Hillrom, iRhythm Technologies Inc., Preventice

Boston Scientific completes Preventice buy, divests BTG Pharmaceutical business

March 2, 2021 By Sean Whooley

Boston Scientific (NYSE:BSX) announced that it completed its acquisition of Preventice Solutions that could be worth up to $1.225 billion. The transaction includes a cash payment of $925 million upfront with up to an additional $300 million in potential commercial milestone payments available. Accounting for the company’s approximately 22% equity stake in Preventice prior to the […]

Filed Under: Business/Financial News, Cardiovascular, Diagnostics, Featured, Health Technology, Mergers & Acquisitions, Pharmaceutical, Software / IT Tagged With: Boston Scientific, BTG, Preventice, SERB

Medical Alley startups raise $1.4B

January 26, 2021 By Sean Whooley

The Medical Alley Association announced that its startups recorded a record-setting year with $1.4 billion in fundraising in 2020. Having broken the $1 billion barrier in 2019, the region topped that mark by the third quarter, raising nearly another half-million by the end of the year, according to a news release. Bright Health and Bind […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Mergers & Acquisitions Tagged With: Boston Scientific, Medical Alley Association, Preventice

MedTech 100 roundup: Another peak for the industry

January 25, 2021 By Sean Whooley

Medtech stocks have been on the rise in 2021, and the past week saw the trend continue with yet another all-time best mark. MassDevice‘s MedTech 100 index reached 107.4 points on Jan. 20, topping the all-time best of 106.81 points set on Jan. 8. That mark represents a 16% jump from the pre-pandemic high of 92.32 […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: Abbott, Amazon, Bardy Diagnostics, Boston Scientific, Cardiva Medical Inc., coronavirus, COVID-19, COVID-19 vaccine, GE Healthcare, Haemonetics, Hillrom, Intuitive Surgical, Joe Biden, MedTech 100 Index, Mesa Biotech, Obalon Therapeutics, Philips, Preventice, ReShape Lifesciences, Thermo Fisher Scientific

Boston Scientific to acquire Preventice Solutions

January 21, 2021 By Sean Whooley

Boston Scientific (NYSE:BSX) announced today that it entered into a definitive agreement to acquire Preventice Solutions. Minneapolis-based Preventice designs mobile health solutions and remote monitoring services for patients with cardiac arrhythmias. Its wearables include the PatientCare platform and BodyGuardian family of monitors. Preventice’s BodyGuardian monitors use a fully-integrated, cloud-based platform for clinical technicians and AI algorithms […]

Filed Under: Business/Financial News, Cardiovascular, Diagnostics, Featured, Health Technology, Mergers & Acquisitions, Software / IT Tagged With: Boston Scientific, Preventice

Medical Alley companies raise $1B in Q3

October 13, 2020 By Sean Whooley

The Medical Alley Association announced today that, through three quarters, its member companies raised more than a record-breaking $1 billion in capital for the first time. Last year, the association’s members raised more than $1 billion over the course of a full year, but this year, the 58 member companies took just three quarters to […]

Filed Under: Business/Financial News, Digital Health, Featured, Funding Roundup Tagged With: CardioMech, CVRx Inc., Medical Alley Association, Preventice

Preventice taps Medtronic exec as new CCO

January 6, 2020 By Sean Whooley

Preventice Solutions announced today that it appointed former Medtronic executive Tom Sheehy as its new executive vice president and chief commercial officer, effective immediately. Sheehy previously served as a senior area sales director for the diagnostics and coronary sales team at medtech giant Medtronic (NYSE:MDT). He also held a national sales leadership role, integrating TYRX antibiotic […]

Filed Under: Business/Financial News, Cardiovascular, Digital Health Tagged With: Medtronic, Personnel Moves, Preventice

HRS 2019 Roundup: Medtronic touts extravascular ICD pilot

May 13, 2019 By Brad Perriello

The pilot study of an extravascular implantable cardiac defibrillator developed by Medtronic (NYSE:MDT), which is designed to deliver both defibrillation and anti-tachycardia pacing using leads placed outside the heart and venous system, showed strong safety and efficacy results. The safety outcome for the 26-patient study, presented last week at the annual meeting of the Heart […]

Filed Under: Cardiovascular, Clinical Trials, Featured Tagged With: AFTx, Biosense Webster, Boston Scientific, Cardiac Rhythm Management, Cardiofocus, HRS 2019, Javelin Medical, Johnson and Johnson, MediLynx, Medtronic, Preventice, Spacelabs Healthcare

HRS 2018 Roundup: Device-related blood clots with Boston Scientific’s Watchman implant

May 11, 2018 By Brad Perriello

Data from a study of device-related blood clots and the Watchman cardiac implant made by Boston Scientific (NYSE:BSX), presented today at the annual meeting of the Heart Rhythm Society in Boston, indicate the need for aggressive management of patients at risk for device-related thrombosis. There were 74 incidences of DRT in 65 of the 1,739 Watchman […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8

Filed Under: Cardiovascular Tagged With: Apple, Bardy Diagnostics, Boston Scientific, Fitbit, HRS 2018, Impulse Dynamics, Imricor Medical Systems Inc., medicalgorithmics, Medtronic, Preventice, samsung

Boston Scientific inks deal with Preventice

August 4, 2015 By Fink Densford

Boston Scientific (NYSE:BSX) said yesterday it inked a sales and marketing deal with cardio-focused remote patient care company Preventice Solutions. The new deal will position medical device giant Boston Scientific as Preventice’s exclusive sales and marketing representative for its cardiology-related diagnostic and monitoring offerings, the companies said. “This agreement marks an important strategic milestone for Preventice Solutions. […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Patient Monitoring, Structural Heart Tagged With: Boston Scientific, Preventice

Second suitor cedes the field early to Zimmer | The week in medtech M&A

September 17, 2014 By MassDevice Leave a Comment

Second suitor ceded early to Zimmer in chase for Biomet

September 12, 2014 by Brad Perriello

Filed Under: Mergers & Acquisitions, News Well Tagged With: Allergan, Avanos Medical (formerly Halyard Health), Biomet, eCardio Diagnostics, Japan Fair Trade Commission, Kimberly-Clark Worldwide Inc., Pershing Square Capital Management, Preventice, Valeant Pharmaceuticals, Zimmer Biomet

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS